Skip to main content

Advertisement

Table 1 Clinical and laboratory data and treatment of the patient during follow-up

From: A novel CLCNKB mutation in a Chinese girl with classic Bartter syndrome: a case report

Age, years 6 7 8 9 10 11 12 13 14
Height, cm (percentile) 97(<3) 111(<3) 119 (3) 126 (10) 132 (10) 143 (25) 150 (25–50) 153 (25–50) 155 (25–50)
Weight, kg (percentile) Serum 13(<3) 18 (3) 22 (25) 23 (10) 26 (10) 34 (25–50) 41 (50) 42 (25–50) 45 (25–50)
BUN, mmol/l (1.7–8.3) a 2.42 2.26 3.73 6.45 4.27 5.32 4.93 6.41 13.49
Cr, umol/l (53–106) a 40.9 48.1 44.3 54.4 56.1 59.2 57 70.9 175
Na, mmol/l (136–146) a 136.2 135.3 136.6 145.4 145.9 139.2 145.1 146.1 145
K, mmol/l (3.5–5.5) a 3.78 3.79 3.35 3.64 3.49 3.57 3.12 3.79 2.99
Cl, mmol/l (97–107) a 92.7 93.3 92.3 103.6 99.5 95.1 105.6 103.5 102.3
HCO3, mmol/l (21–29) a Treatment 33.9 30.6 30.6 29.3 26.8 29.7 24.1 30.2 25.4
recombinant human GH, IU/kg/d 0.1 0.1 0.1 0.15 0.15 0.15
  1. BUN blood urea nitrogen, Cr creatinine, Na sodium, K potassium, Cl chloride, HCO3 bicarbonate
  2. aNormal values in parentheses